Vertex Pharmaceuticals Incorporated VRTX released results from its once-daily vanzacaftor/tezacaftor/deutivacaftor (vanza triple) program for cystic fibrosis (CF), a progressive, multi-organ disease…
Monday, Johnson & Johnson JNJ announced topline results from the pivotal Phase 3 VIVACITY study of nipocalimab in adults living with generalized myasthenia gravis…
© Reuters. On Monday, Hoth Therapeutics Inc. (NASDAQ:) received a positive outlook from H.C. Wainwright, as the firm initiated coverage…
In the green fields of California’s cannabis industry, Aaron Selverston stands tall, a creative driving change with a mix of passion and…
© Reuters. FILE PHOTO: A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston, Massachusetts, U.S.,…